The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Sorrento Therapeutics, Inc(NASDAQ:SRNE) 
Sorrento Therapeutics, Inc., a clinical stage and commercial biopharmaceutical company, develops therapies for cancer, autoimmune, inflammatory, viral, and neurodegenerative diseases. It operates through two segments, Sorrento Therapeutics and Scilex. The company provides cancer therapeutics by leve...
Website: http://www.sorrentotherapeutics.com
Founded: 1989
Full Time Employees: 502 (May 2021)
Sector: Healthcare
Industry: Biotechnology
Sorrento Therapeutics Days Payable Outstanding ttm (DPO)
Sorrento Therapeutics Days Receivable Outstanding ttm (DSO)
Sorrento Therapeutics Days Inventory Outstanding ttm (DIO)
Sorrento Therapeutics Op Cashflow Per Share ttm
Sorrento Therapeutics Free Cashflow Per Share ttm
Sorrento Therapeutics Cash Per Share ttm
Sorrento Therapeutics P/S ratio ttm
Sorrento Therapeutics (GAAP) P/E ratio ttm
Sorrento Therapeutics P/B ratio ttm
No extra charts and metrics for this ticker.